NCT02890160View on ClinicalTrials.gov

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II

NAActive, not recruitingINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

Firesorb

Sirolimus Target Eluting Bioresorbable Vascular Scaffold

DEVICE

XIENCE

Everolimus Eluting Coronary Stent System

Trial Locations (1)

100037

Fu Wai Hospital, Beijing

All Listed Sponsors
lead

Shanghai MicroPort Medical (Group) Co., Ltd.

INDUSTRY